CDSCO

DCGI Gives Emergency Use Okay to Covovax for 12-17 Year Olds

Centre’s Expert Panel Recommends Regular Market Approval for Covishield, Covaxin

Broken Promise: PM Cares Fund Hasn’t Given Rs 100 Crore To Develop COVID Vaccines

Covaxin Booster Has Neutralising Effect on Omicron, Delta: Bharat Biotech

DCGI Okays Covaxin For Young Adults Aged 12-18 Years, With Some Conditions

Drug Given at Mohalla Clinics Caused Death of 3 Children, Govt Says

Serum Institute Seeks DCGI Nod for COVID Vaccine ‘Covovax’